Table: Rohto -Q1 group results

Rohto Pharmaceutical

08/08/2019 07:00

Aug 8 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               41.91               40.64           184.00    
                   (+3.1 pct)          (+13.4 pct)      (+0.2 pct)  
  Operating            3.86                5.06            21.50    
                   (-23.7 pct)         (+47.4 pct)      (+3.3 pct)  
  Recurring            3.92                5.29            21.30    
                   (-25.8 pct)         (+47.1 pct)      (+12.3 pct) 
  Net                  2.22                3.44            13.50    
                   (-35.5 pct)         (+51.2 pct)      (+37.8 pct) 
  EPS               19.46 yen           30.20 yen       118.45 yen  
  EPS Diluted       19.38 yen           30.07 yen                   
  Ann Div                               25.00 yen        26.00 yen  
  -Q2 div                               11.00 yen        13.00 yen  
  -Q4 div                               14.00 yen        13.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T